ZTS ALERT: Securities Fraud Class Action Launched Against Zoetis Inc. - July 27, 2026 Deadline
Levi & Korsinsky, LLP announced that a securities class action lawsuit has been filed against Zoetis Inc. on behalf of investors who purchased securities between January 14, 2025 and May 6, 2026. The complaint alleges that Zoetis concealed weakening adoption of Librela due to FDA safety warnings, market share losses for Simparica Trio, and declining sales for Apoquel and Cytopoint facing new competition.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.